Genetic Engineering and Recombinant DNA

This lesson covers the principles and techniques of genetic engineering — the modification of an organism's genome by introducing genes from another organism — as required by the Edexcel A-Level Biology specification (9BI0, Topic 7).

---

What Is Genetic Engineering?

Genetic engineering (also called genetic modification or recombinant DNA technology) involves isolating a gene from one organism and inserting it into the DNA of another organism. The organism that receives the foreign gene is called a transgenic organism or genetically modified organism (GMO).

The foreign gene is expressed in the host organism, which produces the protein encoded by the transferred gene. This is possible because the genetic code is universal — the same codons specify the same amino acids in all organisms.

---

The Basic Steps of Genetic Engineering

Step 1: Identification and Isolation of the Desired Gene

The gene of interest can be obtained in several ways:

Method	Description
Reverse transcriptase	mRNA from a cell expressing the gene is used as a template to make complementary DNA (cDNA) using the enzyme reverse transcriptase. The cDNA is then made double-stranded using DNA polymerase
Restriction enzymes	The gene is cut out of the genome using restriction endonucleases
PCR	The gene is amplified from genomic DNA using specific primers
Chemical synthesis	Short genes can be synthesised artificially using a gene machine

Exam Tip: Using reverse transcriptase to make cDNA from mRNA is particularly useful for eukaryotic genes because the mRNA has already been spliced — the cDNA will not contain introns. This is important because bacteria cannot splice out introns.

Step 2: Insertion into a Vector

A vector is a carrier molecule used to transfer the gene into the host cell. Common vectors include:

Vector	Description
Plasmids	Small, circular, double-stranded DNA molecules found in bacteria; can replicate independently
Bacteriophages	Viruses that infect bacteria; the gene is inserted into the phage DNA
Artificial chromosomes	BACs (bacterial artificial chromosomes) or YACs (yeast artificial chromosomes) for large DNA inserts

To insert the gene into a plasmid:

1. The plasmid is cut open with the same restriction enzyme used to isolate the gene
2. This produces complementary sticky ends on the plasmid and the gene fragment
3. The gene is mixed with the open plasmid
4. DNA ligase catalyses the formation of phosphodiester bonds, permanently joining the gene to the plasmid
5. The resulting plasmid containing the foreign gene is called recombinant DNA

The following diagram summarises the recombinant DNA process:

flowchart TD
    A["Target Gene<br/>Identified"] --> B["Cut with<br/>Restriction Enzyme"]
    C["Plasmid Vector"] --> D["Cut with Same<br/>Restriction Enzyme"]
    B --> E["Sticky Ends Match"]
    D --> E
    E -->|"DNA Ligase"| F["Recombinant<br/>Plasmid"]
    F --> G["Transformation<br/>into Host Cell"]
    G --> H["Selection<br/>(antibiotic resistance)"]
    H --> I["Clone and Express<br/>Target Protein"]

Step 3: Transformation

Transformation is the process of introducing the recombinant vector into the host cell.

Methods of transformation:

Method	Used for	Mechanism
Heat shock	Bacteria	Cells are incubated in CaCl₂ and briefly heated to 42°C, making the membrane temporarily permeable
Electroporation	Bacteria, eukaryotic cells	A brief electrical pulse creates temporary pores in the membrane
Microinjection	Animal cells	DNA is injected directly into the nucleus using a fine glass needle
Gene gun (biolistics)	Plant cells	Tiny gold or tungsten particles coated with DNA are fired into cells
Agrobacterium	Plant cells	The bacterium Agrobacterium tumefaciens naturally transfers DNA into plant cells
Viral vectors	Animal cells	Modified viruses deliver genes into cells

Step 4: Identification of Successfully Transformed Cells

Not all cells will take up the recombinant vector. Marker genes or reporter genes are used to identify those that have:

Marker	How it works
Antibiotic resistance genes	Cells that have taken up the plasmid grow on antibiotic-containing medium; those without the plasmid die
Fluorescent proteins (e.g. GFP)	Cells with the plasmid glow under UV light
lacZ gene (blue-white screening)	The gene of interest is inserted into the lacZ gene; successful insertion disrupts lacZ, so colonies with the insert are white, while those without are blue on X-gal medium

Exam Tip: Blue-white screening is a common exam topic. Understand that white colonies contain the recombinant plasmid (the inserted gene disrupts beta-galactosidase production), while blue colonies contain the intact plasmid without the insert.

---

Production of Recombinant Proteins

Once the transformed cells are identified, they are cultured in large-scale fermenters (bioreactors) to produce the desired protein.

Example: Production of Human Insulin

1. The human insulin gene is isolated (using mRNA from pancreatic beta cells and reverse transcriptase to make cDNA)
2. The cDNA is inserted into a plasmid vector
3. The recombinant plasmid is transformed into E. coli bacteria
4. Transformed bacteria are selected using antibiotic resistance markers
5. Bacteria are grown in large fermenters under optimal conditions
6. The bacteria express the human insulin gene and produce human insulin protein
7. The insulin is extracted and purified

Before genetic engineering, insulin was extracted from pig or cattle pancreases. Recombinant human insulin (trade name: Humulin) was the first genetically engineered pharmaceutical product, approved in 1982.

Advantages of Recombinant Insulin

Advantage	Explanation
Identical to human insulin	Less likely to cause immune reactions
Unlimited supply	Not dependent on animal slaughter
Consistent quality	Purified to high standards
No ethical/religious concerns	Acceptable to vegetarians, vegans and religious groups who avoid pork/beef
Reduced allergy risk	Animal insulin caused allergic reactions in some patients

---

Genetically Modified Organisms (GMOs)

GM Crops

GM crop	Modification	Benefit
Bt corn/cotton	Gene from Bacillus thuringiensis produces Bt toxin (insecticidal protein)	Reduced pesticide use, increased yield
Golden Rice	Genes for beta-carotene biosynthesis inserted	Addresses vitamin A deficiency
Roundup Ready soybean	Gene for glyphosate resistance	Allows herbicide use to kill weeds without harming crop
Flavr Savr tomato	Antisense gene blocks polygalacturonase	Delayed ripening, longer shelf life

GM Animals

Example	Purpose
Transgenic salmon (AquAdvantage)	Growth hormone gene inserted; fish grow to market size faster
Pharming — transgenic goats/sheep	Human proteins (e.g. antithrombin) produced in milk
Knockout mice	Specific genes inactivated to study gene function

---

Concerns About Genetic Engineering

Concern	Detail
Gene transfer to wild organisms	Antibiotic resistance or herbicide resistance could spread to wild plants/bacteria via horizontal gene transfer
Reduced biodiversity	GM monocultures could replace diverse native species
Unknown long-term effects	Potential unforeseen consequences of consuming GM foods
Ethical issues	"Playing God", designer babies, animal welfare
Corporate control	Patenting of genes; farmers dependent on seed companies
Labelling	Consumers' right to know if food contains GM ingredients

Exam Tip: Exam questions often ask you to evaluate the benefits and risks of genetic engineering. Present a balanced argument — give both advantages and disadvantages, and use specific examples where possible.

---

Summary

Step	Key Process
1. Gene isolation	Reverse transcriptase, restriction enzymes, PCR
2. Insertion into vector	Restriction enzymes + DNA ligase → recombinant DNA
3. Transformation	Heat shock, electroporation, gene gun, viral vectors
4. Selection	Antibiotic resistance, GFP, blue-white screening
5. Expression	Host cells cultured to produce the desired protein

Exam Tip: Be able to describe each step of genetic engineering in detail. A 6-mark question might ask you to explain how a specific protein (like insulin) is produced using recombinant DNA technology.

---

A-Level Deep Dive: Genetic Engineering and Recombinant DNA

Spec mapping

This material sits in Edexcel 9BI0 Topic 8 (Grey Matter — Coordination, Response and Gene Technology), which expects candidates to describe recombinant DNA technology as the directed insertion of a defined gene from one organism into the genome of another, exploiting the universality of the genetic code, the sequence-specific cutting of restriction endonucleases, the end-joining chemistry of DNA ligase, the carrier function of plasmid (and other) vectors, and the selection of transformed cells via antibiotic-resistance or reporter markers. Synoptic links run backwards to lesson 6 on PCR (PCR is the routine way to obtain a clean, abundant copy of the gene of interest before ligation into a vector); to Topic 1 (DNA structure and replication) for the antiparallel double-helix and the chemistry of phosphodiester-bond formation that ligase catalyses; and to Topic 6 (immunity, infection and forensics) for the bacterial restriction-modification system — the evolutionary origin of restriction enzymes as defence against invading bacteriophage DNA — and for recombinant subunit vaccines such as hepatitis B surface antigen produced in yeast. Synoptic links run forwards to lesson 8 on gene therapy and genetic screening (the same molecular toolkit, repurposed for clinical correction of human genetic disease), and to lesson 9 on genomics and bioinformatics (genome sequencing both informs primer / construct design and validates that recombinant inserts integrated as intended). Industrial parallels include insulin since 1982 — the first approved recombinant therapeutic — and the fermentation industry anchored in the same aseptic-culture techniques candidates met in Core Practical 4. Refer to the official Pearson Edexcel 9BI0 specification document for exact wording.

---

Worked example with full mark scheme

Question (8 marks):

(a) Describe how the gene encoding human insulin is isolated, joined to a bacterial plasmid vector, transformed into Escherichia coli, and selected for. (6)

(b) Explain why the cDNA copy of the insulin mRNA — rather than the genomic insulin gene — is used as the starting material for bacterial expression. (2)

Solution with mark scheme:

(a) M1 (AO1) — gene isolation. mRNA is extracted from human pancreatic beta cells (which actively transcribe the insulin gene). Reverse transcriptase uses the mRNA as a template to synthesise a complementary single-stranded cDNA, which is then made double-stranded by DNA polymerase. The cDNA insulin gene can alternatively be obtained by PCR with primers carrying restriction-site tails.

A1 (AO1) — cutting the gene and the plasmid. Both the cDNA and a chosen bacterial plasmid are digested with the same restriction endonuclease — for example EcoRI, which cuts the palindromic recognition sequence 5'-GAATTC-3' between G and A on each strand, leaving complementary single-stranded overhangs (sticky ends). Identical cutting on both molecules guarantees compatible ends.

A1 (AO1) — ligation. The cut plasmid and cDNA are mixed; complementary sticky ends base-pair by hydrogen bonding, and DNA ligase catalyses phosphodiester bond formation across the nicks, sealing the gene permanently into the plasmid backbone. The product is a recombinant plasmid.

A1 (AO2) — transformation. Competent E. coli are mixed with the recombinant plasmid in CaCl₂ and given a brief 42 °C heat shock (alternatively electroporation is used), making the bacterial envelope transiently permeable so a fraction of cells take up the plasmid. Once inside, the plasmid replicates independently of the chromosome.

A1 (AO2) — selection. Transformed cells are plated on agar containing an antibiotic (e.g. ampicillin) for which the antibiotic-resistance gene on the plasmid confers resistance. Only cells carrying the plasmid survive — non-transformed cells die. Successful insert can be confirmed by blue-white screening (insertional inactivation of lacZ) or by colony PCR with insulin-specific primers.

A1 (AO2) — expression and harvest. Selected colonies are scaled up in a fermenter under controlled temperature, pH, oxygenation and nutrient supply; expression is induced (commonly via the lac operon with IPTG); insulin protein is then purified from the culture by affinity chromatography.

(b) M1 (AO3). Human genomic DNA contains introns that must be spliced out of the pre-mRNA by the spliceosome before translation. E. coli is a prokaryote and lacks a spliceosome, so it cannot remove introns from a eukaryotic gene. Inserting genomic insulin DNA would yield a defective mRNA and no functional protein.

A1 (AO3). cDNA is synthesised from the mature, already-spliced mRNA, so it contains only the exon-encoded coding sequence. Bacteria can transcribe and translate it directly, yielding correctly folded human insulin (after the standard proinsulin → insulin processing engineered into the construct).

Total: 8 marks (M2 A6).

---

Specimen question modelled on the Edexcel 9BI0 paper format

Question (6 marks): A biotechnology company wishes to produce human growth hormone (hGH) in E. coli for clinical use. Outline the key steps of the recombinant-DNA workflow they would follow, explaining (i) why cDNA rather than genomic DNA is used, (ii) why the same restriction enzyme is used on the gene and the plasmid, and (iii) how only successfully transformed bacteria are recovered from the population.

Mark scheme decomposition by AO:

Mark	AO	Earned by
1	AO1.1	Stating that the hGH gene is obtained as cDNA by reverse transcription of pituitary mRNA (or PCR-amplified from a cDNA library) and ligated into a bacterial plasmid vector
2	AO1.2	Naming DNA ligase as the enzyme that joins the gene to the plasmid by forming phosphodiester bonds, producing recombinant DNA
3	AO2.1	Explaining that cDNA is used because eukaryotic genomic DNA contains introns which E. coli cannot splice (no spliceosome); cDNA is intron-free coding sequence
4	AO2.7	Explaining that the same restriction enzyme is used on both molecules so they generate complementary sticky ends — base-pairing of those overhangs is what enables ligation in the correct orientation
5	AO3.1	Explaining that an antibiotic-resistance marker on the plasmid lets the company plate the culture on antibiotic-containing agar — only transformed cells survive; further screening (blue-white, colony PCR) confirms the insert is present
6	AO3.2	Synoptic — connecting the workflow to lesson 6 (PCR amplifies the gene of interest), lesson 8 (gene therapy reuses the same toolkit clinically), and Topic 6 (plasmid biology, antibiotic resistance, recombinant subunit vaccines)

Total: 6 marks (AO1 = 2, AO2 = 2, AO3 = 2). Edexcel reliably tests recombinant DNA through "outline the workflow and justify the choices" prompts; candidates who say "the gene is cut out and put in the plasmid" without naming the same restriction enzyme and DNA ligase, or who treat cDNA and genomic DNA as interchangeable, lose AO2 marks. The mark scheme rewards candidates who link same enzyme → matching sticky ends → ligase-mediated phosphodiester bond → recombinant plasmid → selectable transformant.

---

Synoptic links

1. Lesson 6 (PCR and gel electrophoresis). PCR is the routine way to obtain a clean, sequenceable copy of the gene of interest. Restriction-site tails added to the 5' ends of the primers give the amplicon ready-cut compatible ends for ligation. Gel electrophoresis verifies that the cut, the ligation and the colony PCR products are all of the predicted size before the construct is committed to a fermenter run.

2. Lesson 8 (gene therapy and genetic screening). Gene therapy is recombinant-DNA technology applied inside a living patient: the gene of interest (e.g. a functional dystrophin mini-gene, or a CFTR copy) is packaged into a viral vector (AAV, lentivirus) instead of a plasmid, and the host cell is a human somatic cell rather than E. coli. Same molecular toolkit; clinical-grade context, safety and immunogenicity constraints.

3. Lesson 9 (genomics and bioinformatics). Genome sequencing supplies the reference sequence used to design primers, restriction-site choices, and codon-optimised synthetic genes. Long-read and short-read sequencing then validate that an insert integrated as intended (no deletion, no inversion, no off-target integration in stable cell lines).

4. Topic 1 (DNA structure and replication). The phosphodiester-bond chemistry that DNA ligase catalyses is the same chemistry that joins Okazaki fragments on the lagging strand of the replication fork. Ligase did not evolve for biotechnology; biotechnology recruited an existing replication-and-repair enzyme.

5. Topic 6 (vaccines and recombinant subunit antigens). The hepatitis B vaccine is recombinant HBsAg (surface antigen) expressed in yeast (Saccharomyces cerevisiae) carrying a plasmid with the cloned HBV S gene. Recombinant subunit vaccines remove the need to grow live pathogens, and the same workflow underpins HPV (Gardasil) and SARS-CoV-2 spike-protein subunit vaccines.

6. Topic 6 (restriction-modification — the bacterial origin of restriction enzymes). Restriction enzymes are not "tools that bacteria evolved for biologists". They are the immune system of bacteria against invading bacteriophage DNA: bacterial DNA is methylated at the recognition sequence (modification), so self-DNA is protected; unmethylated invading phage DNA is cleaved (restriction). Biotechnology repurposes this defence.

7. Topic 5 (microbiology and biochemical engineering). Industrial recombinant-protein production lives inside the fermentation industry: large-scale stirred-tank bioreactors, controlled temperature/pH/dO₂, defined media, foam control, CIP (clean-in-place) sterilisation, and harvest-stage affinity chromatography. Recombinant insulin is now a multi-tonne-per-year industrial process.

8. GM crops (Bt, Roundup-Ready, Golden Rice). Recombinant-DNA technology in plants typically uses Agrobacterium tumefaciens as the natural vector or a gene gun (biolistics). Bt corn carries a Bacillus thuringiensis insecticidal-protein gene (insect resistance); Roundup-Ready soybean carries a glyphosate-tolerant EPSPS gene (herbicide tolerance); Golden Rice carries beta-carotene biosynthesis genes (vitamin A precursor). The molecular toolkit is the same as for insulin; the host and the regulatory landscape differ.

---

Mark-scheme literacy

AO	Typical share on recombinant-DNA questions	Earned by
AO1 (knowledge)	35–45%	Naming restriction endonucleases (e.g. EcoRI), DNA ligase, plasmid vectors, sticky/blunt ends, cDNA via reverse transcriptase, transformation by heat shock or electroporation, antibiotic-resistance / blue-white selection markers, fermenter culture
AO2 (application)	35–50%	Justifying use of the same restriction enzyme on gene and vector; justifying cDNA over genomic DNA for bacterial hosts; designing primer tails for one-step ligation; choosing a vector appropriate to insert size and host
AO3 (analysis / evaluation)	15–20%	Evaluating risks of GM crops and recombinant therapeutics; balancing benefits (insulin supply, vaccine production, drought-tolerant crops) against concerns (gene flow to wild relatives, antibiotic-resistance markers, corporate control of seed)